HealthTree Logo
search more_vert

Ann LaCasce, MD

Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. Fellowship Program in Hematology/Oncology Chair. Institute Physician. Associate Professor of Medicine, Harvard Medical School.

Clinical Expertise

Clinical Interests

  • CAR T-cell therapy
  • Chronic lymphocytic leukemia
  • Lymphoma
  • Stem cell/bone marrow transplantation

Diseases Treated

  • Leukemia, Chronic Lymphocytic (CLL)
  • Lymphoma, Hodgkin
  • Lymphoma, Non-Hodgkin

About

Ann LaCasce, MD, MMSc, Associate Professor of Medicine, is a lymphoma specialist and is the Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology.  She serves on the Alliance Lymphoma Committee, the National Cancer Comprehensive Lymphoma Guidelines Panel and the Lymphoma Research Foundation’s Scientific Advisory Committee.  

 

Board Certification:

  • Internal Medicine, 1999
  • Medical Oncology, 2002

Fellowship:

  • Dana-Farber/Partners CancerCare, Hematology & Oncology

Residency:

  • Brigham and Women's Hospital, Chief Medical Resident
  • Brigham and Women's Hospital, Internal Medicine

Medical School:

  • Tufts University School of Medicine

Location

Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA

Get the latest thought leadership on CLL delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for CLL Newsletter" for CLL news, life with CLL stories, CLL clinical trials, CLL 101 articles and events with CLL experts.